Paul Arithi 
Hon. Dr Mercy Mwangangi, Chief Administrative Secretary, Ministry of Health, Kenya with Dr. BS Ajaikumar, Executive Chairman, Healthcare Global Enterprises Limited and Dr. Anoo Adamali, Chairman, Cancer Care Kenya Limited during the launch of Elekta’s Versa HD system for advanced cancer treatment at HCG CCK Kenya. The linear accelerator designed to treat a broad spectrum of cancers and significantly enhance patient care.(Photo/Evanter Africa]
HCG CCK Cancer Centre, unit of the Healthcare Global Enterprises Limited leading oncology chain in India, launches Elekta’s Versa HD™, an advanced linear accelerator designed to treat a broad spectrum of cancers and significantly enhance patient care.
Versa HD, the first in sub-Saharan region of Africa, was inaugurated by the chief guest Hon. Dr Mercy Mwangangi, Chief Administrative Secretary, Ministry of Health, Kenya in the presence of Dr. BS Ajaikumar, Executive Chairman, Healthcare Global Enterprises Limited, Dr Manoj Shah, Chairman MP Shah Hospital and Mr. Habib Nehme, Executive Vice President, Elekta.Versa HD provides clinicians with the dual flexibility to deliver conventional therapies to treat a wide range of tumours, as well as high-precision targeted therapies for treating highly complex cancers. As an integrated treatment system, it helps address the evolving challenges of modern- day cancer management while providing patients with best-in-class treatment and high-quality clinical care. The technology helps minimise the radiation dose to healthy tissue and improve quality of life. Cancer patients in Nairobi can now utilize the service for better treatment outcomes.
The Elekta Versa HD will reduce the overall patient treatment duration currently upto 5 to 7 weeks currently for standard treatments to a maximum of 1(one) week with the overall advantage of considerably reduced treatment side effects experienced among patients being treated using hypofractionated regimens. This is enabled through protection of organs at risk and normal tissue.
The Elekta Versa HD can treat up to 150 patients in a day. Patients who utilize the Elekta Versa HD will have an access to the best outpatient Oncology care here at HCGCCK and the region. Patients who travel overseas to receive this specialized treatment annually would not need to because the advanced treatments would available at their doorstep here at Nairobi, Kenya.
Speaking at the occasion, Dr. BS Ajaikumar, Executive Chairman, Healthcare Global Enterprises Limited, said, “Being the pioneers in adopting advanced technologies for cancer therapies, HCG is proud to introduce Elekta’s Versa HD, yet another market-leading innovation. It has been our ceaseless endeavour to provide personalized and precise cancer treatment to our patients. HCG has been at the forefront of adopting cutting-edge technologies in the fight against cancer and the launch of the Versa HD system is a key milestone in this direction.Equipped with this latest technology, HCG CCK Cancer Centre will be better equipped to provide patient-centric, best-in- class medical services.”
Hon. Dr.Mercy Mwangangi, Chief Administrative Secretary, Ministry of Health, Kenya, said, “It is truly commendable that HCG CCK Cancer Centre is the first hospital to introduce this latest technology in the sub-Saharan region of Africa. Elekta’s Versa HD will help improve the quality of life of oncology patients and rationalize treatment costs of tumour diseases in the region. As a leading cancer care specialist, HCG has always been instrumental in bridging the quality and accessibility gap for patients, and with this initiative, we are sure to witness the best treatment outcomes.”
Dr. Manoj Shah, Chairman, MP Shah Hospital, said“Cancer is the second-most cause of mortality across the world, and the launch of Elekta’s Versa HD, will help us provide comprehensive Restricted Information and Basic Personal Data oncology services focused on delivering specialized outcome-based treatments with a multi-disciplinary clinical approach. For the medical team of specialists, this technology will help treat several early to advanced cancers by accurately targeting the most complex tumours.”
Mr. Habib Nehme, Executive Vice President, Elekta, said,“We are excited to collaborate with HCG Cancer hospital, which is committed to enhancing the accessibility of quality cancer care. Elekta is using precision radiation therapy to work towards a future where everyone can benefit from precise and individually tailored radiotherapy treatments.With Versa HD, clinicians can deliver cutting-edge radiation therapy and offer people dealing with cancer a prolonged, disease- free life. Like HCG, our goal is to ensure every patient has access to the best cancer care possible.”
About HCG CCK Cancer Centre:
HCG CCKCancer Centre, Nairobi, Kenya is the first private comprehensive cancer centre in the East African region. This cancer centre offers comprehensive facilities like Radiation Therapy,Surgical Oncology, Medical Oncology, Psycho-Oncology, Palliative Care and Patient Support, all under a single roof. HCG CCK Cancer Centre is well-equipped with state-of-the-art technology,and its multi-disciplinary team of oncologists provide the highest quality of cancer care in the East African region.By virtue of this partnership,HCG has also become the first Indian cancer care hospital to command a presence in the African continent. The cancer centre works on the principle of holding interactive consultations between various sub-specialties in the Tumour Board to decide on the best possible treatment for patients. The patient-focused, individualized, and multidisciplinary therapies ensure faster recoveries and improved Quality of Life for patients.
